EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A SuperSelective primer-based real-time PCR platform for hypersensitive detection of azole resistance in Cryptococcus neoformans

Siddhi Pawar iD, Honglin H Xue, Sophia Wang, Salvatore A E Marras iD, Chaoyang Xue iD

Microbiology Spectrum · 03.11.2026 · 14 (11)

DOI: 10.1128/spectrum.01166-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Siddhi Pawar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA. Hauptthemen laut MEDLINE: Cryptococcus neoformans, Drug Resistance, Fungal, Antifungal Agents, Azoles. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptococcus neoformans is the leading cause of fungal meningitis with limited treatment options, making early and accurate diagnosis critical for improved patient outcomes. Current diagnostic methods for cryptococcosis rely largely on capsule antigen detection and fungal culture, which are time-consuming and unable to identify mutation-driven antifungal resistance. In this study, we have developed a SuperSelective primer-based PCR (SSP-PCR) platform for the rapid and specific detection of azole resistance-associated single-nucleotide polymorphisms (SNPs). We demonstrate that SSP-PCR reliably detected a single copy of mutant allele in the presence of excess wild-type (WT) DNA, with sensitivity reaching a 1:10 4 mutant-to-WT ratio. Incorporating molecular beacon (MB) probes into our SSP-PCR platform further enhanced amplification specificity, enabling selective detection of the ERG11 Y145F (A434T) mutation, which is known to confer high azole resistance. Using genomic DNA from in vitro cultures and mouse lung tissues infected with either WT strain H99 or a fluconazole-hyper-resistant mrl1 clinical isolate that carries the ERG11 (A434T) mutation, or both strains, we successfully detected the A434T mutant allele in both settings. Moreover, our SSP-PCR simultaneously identified ERG11 (A434T) and the multi-azole resistance-associated ERG11 (G1885A) mutant alleles in a single-tube duplex reaction. Collectively, this is the first study that utilizes the SSP-PCR platform to provide a robust and ultrasensitive molecular approach for the detection of azole resistance in C. neoformans, which provides a proof-of-concept methodology for its potential high-throughput clinical screening applications. IMPORTANCE Invasive fungal infections are a growing public health threat causing over 1.5 million deaths annually, with cryptococcal meningitis accounting for over 15% of HIV/AIDS-related mortality. The problem is aggravated by limited treatment options and emerging drug resistance. Long-term use of fungistatic azoles like fluconazole promotes the emergence of azole resistance and heteroresistance, contributing to clinical treatment failure. Current diagnostic assays often fail to detect resistance-associated mutations within heterogeneous fungal populations, limiting their clinical utility. In this study, we developed a SuperSelective primer-based PCR (SSP-PCR) platform for the rapid and ultrasensitive detection of azole resistance-associated single-nucleotide polymorphisms (SNPs) in Cryptococcus neoformans . By integrating molecular beacon probes, this assay achieves high specificity and enables the detection of multiple SNP mutations in a single reaction. Our SSP-PCR platform offers a powerful molecular approach for identifying azole resistance with the potential to improve diagnostic precision and guide antifungal therapy in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cryptococcus neoformansDrug Resistance, FungalAntifungal AgentsAzolesCryptococcosisReal-Time Polymerase Chain ReactionAnimalsMicePolymorphism, Single NucleotideSensitivity and SpecificityDNA PrimersHumansFungal ProteinsMicrobial Sensitivity TestsMutation

Stichwörter der Autor:innen

Cryptococcus neoformansSuperSelective primerfluconazolemolecular beaconresistance

Substanzen

Antifungal AgentsAzolesDNA PrimersFungal Proteins

Autor:innen und Institutionen

  • Public Health Research Institute, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.
  • Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey, USA.

ORCID-Profile: Siddhi Pawar, Salvatore A E Marras, Chaoyang Xue

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Cancer Institute

Zitieren

APA

Pawar, S., Xue, H. H., Wang, S., Marras, S. A. E., & Xue, C. (2026). A SuperSelective primer-based real-time PCR platform for hypersensitive detection of azole resistance in Cryptococcus neoformans. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.01166-26

Vancouver

Pawar S, Xue HH, Wang S, Marras SAE, Xue C. A SuperSelective primer-based real-time PCR platform for hypersensitive detection of azole resistance in Cryptococcus neoformans. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.01166-26

BibTeX
@article{Pawar2026,
  author = {Pawar, Siddhi and Xue, Honglin H and Wang, Sophia and Marras, Salvatore A E and Xue, Chaoyang},
  title = {A SuperSelective primer-based real-time PCR platform for hypersensitive detection of azole resistance in Cryptococcus neoformans},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1128/spectrum.01166-26}
}
Kostenlos starten →